Watertown, MA, United States

EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares

EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares

2024-10-31 23:52

EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering

WATERTOWN, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced th…

2024-10-30 01:47

History in the (Curriculum) Making

History in the (Curriculum) Making mjorgensen Tue, 10/29/2024 - 10:42 curriculum history Student and Alumni Stories Lory Hough October 29, 2024 Ed. Mag…

2024-10-29 14:42

EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock

WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced th…

2024-10-28 21:14

Atomic Annie: The Army Built the World's Only Nuclear Artillery 'Cannon'

What You Need to Know: The M65 "Atomic Annie," introduced in 1952, was the world’s only nuclear artillery cannon. With an impressive range of 30 miles and armed with a 15-kiloton nuclear warhead, the 280mm gun was developed post-WWII as a Cold War deterrent. …

2024-10-28 19:58

Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week

WATERTOWN, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic …

2024-10-25 17:00

EyePoint Pharmaceuticals Announces First Patient Dosed in Global Phase 3 LUGANO Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration

– Second Phase 3 LUCIA pivotal trial first patient dosing expected by end of 2024 – – Topline data anticipated in 2026 – WATERTOWN, Mass., Oct....

2024-10-24 11:00

Dem Sen. Tammy Baldwin, with nine terms in Congress, pushes Supreme Court term limits in heated debate

WATERTOWN, Wis. — In a tightly controlled debate format, Democratic Sen. Tammy Baldwin and Republican businessman Eric Hovde traded barbs Friday night in their first and likely only face-off, hosted by the Wisconsin Broadcasters Association. Baldwin and Hovde…

2024-10-19 04:04

Acrivon Therapeutics (NASDAQ:ACRV) & Aquestive Therapeutics (NASDAQ:AQST) Head to Head Analysis

Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) and Aquestive Therapeutics (NASDAQ:AQST – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profita…

2024-10-18 09:48

Farmville fight: Swing-state ag groups offer rival endorsements for key Senate race

WATERTOWN, Wis. — The Wisconsin Farm Bureau Federation’s endorsement of Sen. Tammy Baldwin — its first statewide Democratic nod in more than 20 years — has raised eyebrows in the Dairy State. Farmers told The Post they want to send someone with business exper…

2024-10-17 17:42